You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Squamous cell carcinoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai chest hospital
Sep 24, 2023

Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • (no location specified)
Aug 28, 2023

Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • PET/CT
  • Neck dissection
  • (no location specified)
Jan 31, 2023

Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • LDRT+CFRT
  • +2 more
  • Shanghai, China
  • +1 more
Aug 3, 2023

Resectable Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial (cadonilimab+chemo)

Not yet recruiting
  • Resectable Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Apr 18, 2023

HLA-DR in Cell Cultures Isolated From Primary Squamous Cell

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Cancer
  • cell culture
  • Roma, Lazio, Italy
    Fondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023

Salivary LINC00657 asDiagnostic Biomarker for Oral Squamous Cell

Completed
  • Oral Squamous Cell Carcinoma
    • Fayoum, Egypt
      faculty of dentistry, Fayoum university
    Apr 19, 2023

    Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
    • Black Raspberry
    • (no location specified)
    Oct 16, 2023

    Esophageal Squamous Cell Carcinoma Trial in Shantou (Tislelizumab)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Shantou, Guangdong, China
      Cancer Hospital of Shantou University Medical College
    Aug 2, 2023

    Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
    • (no location specified)
    Mar 17, 2023

    Needs and Preferences of Patients With Head-neck Cutaneous SCC

    Active, not recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +10 more
    • Regular care with additional administration of a semi-structured interview
    • Maastricht, Netherlands
      Maastricht University Medical Center+
    Sep 13, 2023

    Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Skin
    • Carrilizumab with albumin-binding paclitaxel
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    May 23, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Nab paclitaxel
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital
    Aug 24, 2023

    Advanced Lung Squamous Cell Carcinoma

    Not yet recruiting
    • Advanced Lung Squamous Cell Carcinoma
    • No treatment is included in this study
    • Changsha, Hunan, China
      Yongchang Zhang
    Aug 11, 2023

    Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Locally Advanced Operable
    • Guangzhou, Guangdong, China
    • +1 more
    Sep 4, 2023

    Esophageal Squamous Cell Carcinoma Trial in Wuhan (Intensity-modulated radiotherapy (IMRT), Tislelizumab, Cisplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Intensity-modulated radiotherapy (IMRT)
    • +3 more
    • Wuhan, Hubei, China
      Renmin hosptial of Wuhan University
    Jun 16, 2023

    Oral Squamous Cell Carcinoma Trial (Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum Triple Therapy
    • (no location specified)
    Nov 11, 2023

    Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Head and Neck Cancer
    • (no location specified)
    Jun 9, 2023

    Esophageal Squamous Cell Carcinoma (ESCC), PD-1 Inhibitors Trial in Zhengzhou (IBI110+Sintilimab)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma (ESCC)
    • PD-1 Inhibitors
    • Zhengzhou, Henan, China
      Feng Wang
    Oct 9, 2023

    Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Neck Dissection
    • Elective neck dissection
    • Therapeutic neck dissection
    • (no location specified)
    Apr 10, 2023

    Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Chengdu (Netopitam Palonosetron capsules and dexamethasone)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
    • Netopitam Palonosetron capsules and dexamethasone
    • Chengdu, Sichuan, China
      Sichuan Cancer Hospital and Research Institute
    Oct 22, 2023

    People Living With HIV, Oral and Oropharyngeal Cancer, and

    Not yet recruiting
    • HIV Infections
    • +2 more
    • Group Meeting (Focus Group)
    • Questionnaires
    • San Francisco, California
      University of California, San Francisco
    Sep 20, 2023

    Head and Neck Squamous Cell Carcinoma Trial (Zanzalintinib, Zanzalintinib-matched Placebo, Pembrolizumab)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Oct 9, 2023

    Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

    Not yet recruiting
    • Neoplasms
    • +2 more
    • Nivolumab Injection [Opdivo]
    • (no location specified)
    Jul 19, 2023

    ctDNA-MRD in Predicting Efficacy of Esophageal Squamous Cell

    Not yet recruiting
    • Squamous Cell Carcinoma of Esophagus
      • (no location specified)
      Feb 25, 2023